Fingerprint
Dive into the research topics of 'Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment
Richard Kim, E. Gabriela Chiorean, Manik Amin, Caio Max S. Rocha-Lima, Jitendra Gandhi, William P. Harris, Tao Song, David Portnoy
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations